Strides Pharma Science Limited (NSE:STAR)
India · Delayed Price · Currency is INR 864.85
+14.20 (1.67%)
At close: Mar 6, 2026
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 79.72 billion as of March 6, 2026. Its market cap has increased by 27.25% in one year.
Market Cap
79.72B
Enterprise Value
96.35B
Revenue
47.26B
Ranking
n/a
PE Ratio
15.59
Stock Price
864.85
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 79.72B, an increase of 963.73%. That is a compound annual growth rate of 9.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 79.72B | -3.94% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 201.66B |
| Eris Lifesciences | 188.49B |
| NATCO Pharma | 182.64B |
| Alembic Pharmaceuticals | 139.26B |
| Alivus Life Sciences | 112.31B |
| Cohance Lifesciences | 107.08B |
| Akums Drugs and Pharmaceuticals | 72.62B |
| Aarti Pharmalabs | 63.47B |